Literature DB >> 23681204

High polarization of nuclear spins mediated by nanoparticles at millikelvin temperatures.

John R Owers-Bradley1, Anthony J Horsewill, David T Peat, Kelvin S K Goh, David G Gadian.   

Abstract

Nuclear magnetic resonance (NMR) techniques are extensively used in many areas of basic and clinical research, as well as in diagnostic medicine. However, NMR signals are intrinsically weak, and this imposes substantial constraints on the amounts and concentrations of materials that can be detected. The signals are weak because of the low energies characteristic of NMR and the resulting very low (typically 0.0001-0.01%) polarization of the nuclear spins. Here, we show that exposure to very low temperatures and high magnetic fields, in conjunction with nanoparticle-mediated relaxation enhancement, can be used to generate extremely high nuclear polarization levels on a realistic timescale; with copper nanoparticles at 15 mK and 14 T, (13)C polarization grew towards its equilibrium level of 23% with an estimated half-time of about 60 hours. This contrasts with a (13)C half-time of at least one year in the presence of aluminium nanoparticles. Cupric oxide nanoparticles were also effective relaxation agents. Our findings lead us to suspect that the relaxation may be mediated, at least in part, by the remarkable magnetic properties that some nanoparticle preparations can display. This methodology offers prospects for achieving polarization levels of 10-50% or more for many nuclear species, with a wide range of potential applications in structural biology and medicine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681204     DOI: 10.1039/c3cp51274f

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  1 in total

1.  Use of Nuclear Spin Noise Spectroscopy to Monitor Slow Magnetization Buildup at Millikelvin Temperatures.

Authors:  Maria Theresia Pöschko; David Peat; John Owers-Bradley; Norbert Müller
Journal:  Chemphyschem       Date:  2016-07-22       Impact factor: 3.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.